PMH13: PRE-TREATMENT PATIENT DIFFERENCES: CHOICE OF DRUG THERAPY WITHIN SCHIZOPHRENIA

sodium valproate as an adjunctive drug in treatment of schizophrenia

objective: although sodium valproate came to the market as an anticonvulsant drug, nowadays it's wildly used in the management of psychiatric disorders. it is used as a mood stabilizer and as an adjunctive agent in treatment of depression and psychosis. there are controversies regarding sodium valproate efficacy in psychosis. although some studies have reported that it is effective in the ...

What influences patient choice of treatment modality at the pre-dialysis stage?

BACKGROUND There is little information on factors influencing patient choice of renal replacement modality (RRM) in the UK. Pre-dialysis education programmes have been associated with increased uptake of peritoneal dialysis (PD) in other countries but their relevance in informing patient choice within UK centres has not been extensively studied. In this study, we examined how patient choice of ...

Treatment of the special patient with schizophrenia

Special patient populations with schizophrenia have received little attention. These populations include adolescents, the elderly, substance abusers, and patients who are considered treatment-resistant. Interest in these populations is rapidly growing, especially with regard to their treatment with second-generation antipsychotics. This article describes the treatment of special patient populat...

Schizophrenia relapse in relation to drug treatment.

OBJECTIVE To assess and compare, prospectively, schizophrenia relapse in relation to neuroleptic medication in long term maintenance therapy. METHODS All schizophrenic patients who met the DSM-IV criteria attending King Khalid University Hospital psychiatry outpatient clinic, Riyadh, Kingdom of Saudi Arabia in January 1994, and who fulfilled the inclusion criteria of the study, were assessed ...

Informed Patient Choice in Treatment Abroad - A Response to Recent Commentaries